Le Lézard
Classified in: Health
Subject: CCA

BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call



FRANKLIN LAKES, N.J., Oct. 5, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2017 earnings conference call on Thursday, November 2, 2017, at 8:00 a.m. (ET).  BD will issue a press release detailing the quarter's earnings earlier that morning.

The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available for replay through Thursday, November 9, 2017.    

About BD 
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has nearly 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.

Contact:
Kristen Cardillo, Communications ? 201-847-5657
Monique N. Dolecki, Investor Relations ? 201-847-5378

SOURCE BD (Becton, Dickinson and Company)


These press releases may also interest you

at 18:33
Kane Biotech Inc. , (the "Corporation" or "Kane Biotech") today announced that it has received a loan (the "Loan") in the amount of $500,000 from Individual Investment Corporation, an arm's length third-party lender (the "Lender"). The Loan bears...

at 17:31
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved SYMTUZAtm, the first and only complete, darunavir-based single-tablet regimen (STR) for the treatment of human...

at 17:20
Treatment Management Company, a leading provider of drug and alcohol treatment programs, has named Ray Velazquez as chief executive officer. Velazquez is an entrepreneur and international business executive with extensive experience in starting and...

at 17:03
AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility, today announced that...

at 17:00
Ruben U. Carvajal, MD recently discovered an incident that may impact certain Ruben U. Carvajal, MD patient information.  On January 3, 2018, Dr. Carvajal received a report that certain Ruben U. Carvajal, MD patient information may have been...

at 17:00
The "Epiomic Epidemiology Series: Hidradenitis Suppurativa Forecast In 21 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering. Epiomic Epidemiology Forecast Report on Hidradenitis Suppurativa in 21 Major Markets...




News published on 5 october 2017 at 16:30 and distributed by: